Artivion (AORT) Revenue Growth (3y) (2013 - 2026)
Artivion (AORT) Revenue Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.00 Bn | 175.71 Bn | 6.27 Bn | 4.63% |
| 2 | Stryker | 128.69 Bn | 125.81 Bn | 3.81 Bn | 8.01% |
| 3 | Medtronic | 108.82 Bn | 99.60 Bn | 6.41 Bn | 4.70% |
| 4 | Boston Scientific | 68.39 Bn | 66.93 Bn | 3.61 Bn | 15.36% |
| 5 | Edwards Lifesciences | 47.97 Bn | 44.30 Bn | 1.29 Bn | 10.52% |
| 6 | GE HealthCare Technologies | 28.29 Bn | 26.00 Bn | 1.98 Bn | 2.92% |
| 7 | Dexcom | 28.21 Bn | 27.09 Bn | 750.30 Mn | 17.14% |
| 8 | Smith & Nephew | 26.91 Bn | 26.33 Bn | - | - |
| 9 | Koninklijke Philips | 25.45 Bn | 22.32 Bn | 2.07 Bn | 0.73% |
| 10 | Artivion | 1.25 Bn | 1.20 Bn | 75.45 Mn | 11.81% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.81% |
| Dec 31, 2025 | 13.47% |
| Sep 30, 2025 | 13.85% |
| Jun 30, 2025 | 12.03% |
| Mar 31, 2025 | 8.63% |
| Dec 31, 2024 | 7.02% |
| Sep 30, 2024 | 9.87% |
| Jun 30, 2024 | 8.78% |
| Mar 31, 2024 | 11.08% |
| Dec 31, 2023 | 11.32% |
| Sep 30, 2023 | 10.49% |
| Jun 30, 2023 | 18.40% |
| Mar 31, 2023 | 7.81% |
| Dec 31, 2022 | 4.44% |
| Sep 30, 2022 | 4.22% |
| Jun 30, 2022 | 4.14% |
| Mar 31, 2022 | 4.58% |
| Dec 31, 2021 | 5.40% |
| Sep 30, 2021 | 3.78% |
| Jun 30, 2021 | 3.59% |